Symbols

ALBT

Avalon Globocare·NASDAQ

--(--)

Market Open: --

--(--)

Pre-Market: --

Signals Analysis

Bullish signal 1

Bearish signal 0

MACD Golden Cross

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About ALBT

Avalon Globocare Corp

A leading global developer of innovative cell-based technologies and therapeutics

Industry

Biological Technology

Established Date

07/28/2014

Listing Date

11/05/2018

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.avalon-globocare.com

Security Type

Common stock

Office address

4400 Route 9 South, Suite 3100, Freehold, New Jersey 07728

Business

Introduction

Avalon Globocare Corp was incorporated under the laws of the State of Delaware on July 28, 2014. Avalon GloboCare Corpare is committed to integrating and managing global healthcare services and resources, as well as empowering high-impact biomedical innovations and technologies to accelerate their clinical application. The company's "technology + services" ecosystem covers the fields of regenerative medicine, cellular immunotherapy, exosomal technology and rehabilitation medicine through two main platforms, "Avalon Cell" and "Avalon Rehab". The company plans to integrate these services through joint ventures and value-added acquisitions in the short term through operating entities (as part of Avalon Rehab) and in the long term through biomedical innovation development as part of Avalon Cell (such as their recent joint venture) exosome separation systems and related products.

Company Financials

EPS

ALBT has released its 2025 Q2 earnings. EPS was reported at -6.22, versus the expected 0, missing expectations. The chart below visualizes how ALBT has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

ALBT has released its 2025 Q3 earnings report, with revenue of 350.10K, reflecting a YoY change of 1.43%, and net profit of -254.27K, showing a YoY change of 84.86%. The Sankey diagram below clearly presents ALBT's revenue sources and cost distribution.